Investigating the Effect of Montelukast on the Pyelonephritis Symptoms in Children

AuthorHassan Taherahmadien
AuthorParsa Yousefichaijanen
AuthorMasoud Rezagholizamenjanyen
AuthorManijeh Kahbazien
AuthorTayebe Nazarien
OrcidParsa Yousefichaijan [0000-0002-6243-431X]en
OrcidMasoud Rezagholizamenjany [0000-0002-5824-2366]en
Issued Date2019-11-30en
AbstractBackground: Montelukast as an anti-inflammatory drug has a protective effect on the kidney’s tissue and also on children with pyelonephritis. Objectives: Therefore, this study aimed at investigating the effect of montelukast on the pyelonephritis symptoms in children. Methods: In this study, 100 children with pyelonephritis were divided into two groups, including the intervention (n = 50) and control (n = 50) groups. Patients in both groups received routine antibiotic therapy and in the intervention group, montelukast (5 mg/day, oral) was prescribed (for 14 days). Finally, the clinical manifestations of the patients were evaluated and compared between two groups. Results: The mean age (± SD) in intervention and control groups was 7.2 (± 0.43) and 7.18 (± 0.43) years, respectively. Analysis of the results showed that the duration of fever (P < 0.0001), dysuria (P < 0.0001), abdominal pain (P < 0.0001) and urgency (P = 0.003) were significantly lower in the intervention group than the control group. Conclusions: Montelukast lead to rapid improvement of clinical manifestations in children with pyelonephritis and may can be used as an effective auxiliary treatment in these patients.en
DOIhttps://doi.org/10.5812/numonthly.96626en
KeywordMontelukasten
KeywordPyelonephritisen
KeywordSymptomsen
KeywordChildrenen
PublisherBrieflandsen
TitleInvestigating the Effect of Montelukast on the Pyelonephritis Symptoms in Childrenen
TypeResearch Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
num-11-4-96626.pdf
Size:
111.94 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF